Anti-HER3 antibodies and compositions

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9217039
APP PUB NO 20130287684A1
SERIAL NO

13882807

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to novel therapeutic recombinant antibodies directed against HER3 (ErbB3), as well as compositions comprising mixtures of at least two of said recombinant anti-HER3 antibodies, and use of the antibodies and antibody compositions for treatment of cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SYMPHOGEN A/S2750 BALLERUP

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Jacobsen, Helle Virum, DK 9 62
Koefoed, Klaus København S, DK 23 255
Pedersen, Mikkel Wandahl Alleroed, DK 24 224

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 22, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00